Qiagen NV | QIA - Ebit

Stock Price
43.73
Daily Change
-0.31 -0.69%
Monthly
12.50%
Yearly
4.38%
Q1 Forecast
43.53

Qiagen NV reported $141.06M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Alaunos Therapeutics USD -1.19M 148K Sep/2025
argenx SE USD 349.97M 61.94M Sep/2025
Avita Medical AUD -8.66M 1.61M Jun/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Ionis Pharmaceuticals USD -160.18M 304.96M Sep/2025
IQVIA Holdings USD 573M 17M Sep/2025
Moderna USD -260M 557M Sep/2025
Organon & Co USD 388M 28M Sep/2025
Qiagen NV USD 141.06M 6.64M Sep/2025
Revvity USD 98.34M 7.58M Sep/2025
Tectonic Therapeutic USD -22.33M 4.03M Jun/2025
Viatris USD 234.5M 49.1M Sep/2025
Xeris Pharmaceuticals USD 7.89M 2.46M Sep/2025